Delivery Order SPE2DB20D2104-SPE2DB25FMYAS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,788.01 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen/ml on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $50,801.12 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of SKYRIZI 150 mg/mL pen/mL, a pharmaceutical product used to treat inflammatory conditions. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 24, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,371.82, is a delivery order for the supply of SKYRIZI 150 MG/ML PENML, a medication used for medical treatment. The contract has a firm fixed price and an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $17,574.35 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen vials under a firm fixed price contract type. This competitive award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $44,915.10 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of SKYRIZI 150 mg/mL pen/mL, a specialty pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, is a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 24, 2025, for SKYRIZI 150 mg/mL pens valued at $17,794.40 under a firm fixed price arrangement. This non-set-aside award is scheduled for completion by July 25, 2025, with delivery performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order valued at $25,368.86 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml, a pharmaceutical product, on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen, a pharmaceutical product used in dermatological treatment. This firm fixed-price delivery order, awarded on July 23, 2025, is classified as non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. The award represents a child contract under...
- The Defense Logistics Agency awarded a $12,962.95 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of SKYRIZI 150 mg/ml pen injections. This is a firm fixed-price contract with an ultimate completion date of July 28, 2025, and was competitively awarded with no set-aside designation. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $37,510.45 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL, a pharmaceutical product. This firm fixed price contract, issued on July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply agreement running through December 2026. The contract was competitively awarded...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYASDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of SKYRIZI 150 mg/ml pen/ml, a prescription pharmaceutical product. This competitive delivery order, utilizing firm fixed price pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract carries an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial prime IDC with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, designated as SPE2DX. This comprehensive global pharmaceutical support vehicle enables the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company serves critical federal customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract framework, positioning it as a key vendor for federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 8/15/25 |